These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 14726380)

  • 1. Bioengineering of coagulation factor VIII for improved secretion.
    Miao HZ; Sirachainan N; Palmer L; Kucab P; Cunningham MA; Kaufman RJ; Pipe SW
    Blood; 2004 May; 103(9):3412-9. PubMed ID: 14726380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of factor VIII transgenes bioengineered for improved expression in gene therapy of hemophilia A.
    Dooriss KL; Denning G; Gangadharan B; Javazon EH; McCarty DA; Spencer HT; Doering CB
    Hum Gene Ther; 2009 May; 20(5):465-78. PubMed ID: 19222367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical chaperones improve protein secretion and rescue mutant factor VIII in mice with hemophilia A.
    Roth SD; Schüttrumpf J; Milanov P; Abriss D; Ungerer C; Quade-Lyssy P; Simpson JC; Pepperkok R; Seifried E; Tonn T
    PLoS One; 2012; 7(9):e44505. PubMed ID: 22973456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and characterization of a codon-optimized blood coagulation factor VIII.
    Shestopal SA; Hao JJ; Karnaukhova E; Liang Y; Ovanesov MV; Lin M; Kurasawa JH; Lee TK; Mcvey JH; Sarafanov AG
    J Thromb Haemost; 2017 Apr; 15(4):709-720. PubMed ID: 28109042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioengineering of coagulation factor VIII for efficient expression through elimination of a dispensable disulfide loop.
    Selvaraj SR; Scheller AN; Miao HZ; Kaufman RJ; Pipe SW
    J Thromb Haemost; 2012 Jan; 10(1):107-15. PubMed ID: 22044596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LMAN1 is a molecular chaperone for the secretion of coagulation factor VIII.
    Cunningham MA; Pipe SW; Zhang B; Hauri HP; Ginsburg D; Kaufman RJ
    J Thromb Haemost; 2003 Nov; 1(11):2360-7. PubMed ID: 14629470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Therapy with BMN 270 Results in Therapeutic Levels of FVIII in Mice and Primates and Normalization of Bleeding in Hemophilic Mice.
    Bunting S; Zhang L; Xie L; Bullens S; Mahimkar R; Fong S; Sandza K; Harmon D; Yates B; Handyside B; Sihn CR; Galicia N; Tsuruda L; O'Neill CA; Bagri A; Colosi P; Long S; Vehar G; Carter B
    Mol Ther; 2018 Feb; 26(2):496-509. PubMed ID: 29292164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A.
    Nguyen GN; George LA; Siner JI; Davidson RJ; Zander CB; Zheng XL; Arruda VR; Camire RM; Sabatino DE
    J Thromb Haemost; 2017 Jan; 15(1):110-121. PubMed ID: 27749002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Codon optimization of human factor VIII cDNAs leads to high-level expression.
    Ward NJ; Buckley SM; Waddington SN; Vandendriessche T; Chuah MK; Nathwani AC; McIntosh J; Tuddenham EG; Kinnon C; Thrasher AJ; McVey JH
    Blood; 2011 Jan; 117(3):798-807. PubMed ID: 21041718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin.
    Pipe SW; Morris JA; Shah J; Kaufman RJ
    J Biol Chem; 1998 Apr; 273(14):8537-44. PubMed ID: 9525969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal modification in the factor VIII B-domain sequence ameliorates the murine hemophilia A phenotype.
    Siner JI; Iacobelli NP; Sabatino DE; Ivanciu L; Zhou S; Poncz M; Camire RM; Arruda VR
    Blood; 2013 May; 121(21):4396-403. PubMed ID: 23372167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII.
    Pittman DD; Alderman EM; Tomkinson KN; Wang JH; Giles AR; Kaufman RJ
    Blood; 1993 Jun; 81(11):2925-35. PubMed ID: 8499631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable expression of native Coagulation factor VIII using the 2A self-processing sequence and furin cleavage site.
    He B; Pan Y; Chen L; Xu Y; Chen N; Gu L; Nie Z; Wang S; Liu Z
    Thromb Res; 2011 Dec; 128(6):e148-53. PubMed ID: 21803400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable high-level expression of factor VIII in Chinese hamster ovary cells in improved elongation factor-1 alpha-based system.
    Orlova NA; Kovnir SV; Gabibov AG; Vorobiev II
    BMC Biotechnol; 2017 Mar; 17(1):33. PubMed ID: 28340620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor.
    Jacquemin M; Lavend'homme R; Benhida A; Vanzieleghem B; d'Oiron R; Lavergne JM; Brackmann HH; Schwaab R; VandenDriessche T; Chuah MK; Hoylaerts M; Gilles JG; Peerlinck K; Vermylen J; Saint-Remy JM
    Blood; 2000 Aug; 96(3):958-65. PubMed ID: 10910910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient adenoviral vector transduction and expression of functional human factor VIII in cultured primary human hepatocytes.
    Andrews JL; Weaver L; Kaleko M; Connelly S
    Haemophilia; 1999 May; 5(3):160-8. PubMed ID: 10444282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confocal microscopy analysis of native, full length and B-domain deleted coagulation factor VIII trafficking in mammalian cells.
    Becker S; Simpson JC; Pepperkok R; Heinz S; Herder C; Grez M; Seifried E; Tonn T
    Thromb Haemost; 2004 Jul; 92(1):23-35. PubMed ID: 15213841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors.
    Chuah MK; Schiedner G; Thorrez L; Brown B; Johnston M; Gillijns V; Hertel S; Van Rooijen N; Lillicrap D; Collen D; VandenDriessche T; Kochanek S
    Blood; 2003 Mar; 101(5):1734-43. PubMed ID: 12406898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation factors with improved properties for hemophilia gene therapy.
    Pipe SW
    Semin Thromb Hemost; 2004 Apr; 30(2):227-37. PubMed ID: 15118934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circumventing furin enhances factor VIII biological activity and ameliorates bleeding phenotypes in hemophilia models.
    Siner JI; Samelson-Jones BJ; Crudele JM; French RA; Lee BJ; Zhou S; Merricks E; Raymer R; Nichols TC; Camire RM; Arruda VR
    JCI Insight; 2016 Oct; 1(16):e89371. PubMed ID: 27734034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.